Private Trust Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.28M Sell
48,857
-1,287
-3% -$151K 0.5% 25
2026
Q1
$6.03M Buy
50,144
+1,179
+2% +$136K 0.54% 26
2025
Q4
$5.15M Buy
48,965
+4,381
+10% +$411K 0.45% 33
2025
Q3
$3.74M Buy
44,584
+207
+0.5% +$17.1K 0.33% 49
2025
Q2
$3.51M Buy
44,377
+699
+2% +$55.6K 0.33% 55
2025
Q1
$3.92M Buy
43,678
+641
+1% +$59.8K 0.4% 42
2024
Q4
$4.28M Sell
43,037
-3
-0% -$309 0.44% 38
2024
Q3
$4.89M Sell
43,040
-6,464
-13% -$768K 0.49% 34
2024
Q2
$6.13M Sell
49,504
-390
-0.8% -$50.2K 0.66% 22
2024
Q1
$6.58M Sell
49,894
-405
-0.8% -$49.9K 0.71% 23
2023
Q4
$5.48M Buy
50,299
+16
+0% +$1.66K 0.64% 25
2023
Q3
$5.18M Sell
50,283
-583
-1% -$62.8K 0.68% 25
2023
Q2
$5.87M Sell
50,866
-104
-0.2% -$11.8K 0.74% 17
2023
Q1
$5.42M Buy
50,970
+5,214
+11% +$563K 0.74% 20
2022
Q4
$5.08M Buy
45,756
+614
+1% +$62.8K 0.75% 22
2022
Q3
$3.89M Buy
45,142
+2,841
+7% +$254K 0.63% 26
2022
Q2
$3.86M Sell
42,301
-8,602
-17% -$763K 0.6% 29
2022
Q1
$4.18M Buy
50,903
+8,431
+20% +$665K 0.65% 36
2021
Q4
$3.25M Sell
42,472
-996
-2% -$79.3K 0.45% 55
2021
Q3
$3.27M Sell
43,468
-1,342
-3% -$102K 0.48% 50
2021
Q2
$3.48M Sell
44,810
-3,477
-7% -$259K 0.53% 44
2021
Q1
$3.55M Buy
48,287
+995
+2% +$73.4K 0.58% 41
2020
Q4
$3.69M Buy
47,292
+342
+0.7% +$26.2K 0.62% 34
2020
Q3
$3.72M Buy
46,950
+373
+0.8% +$29.2K 0.72% 26
2020
Q2
$3.54M Buy
46,577
+1,607
+4% +$121K 0.74% 29
2020
Q1
$3.3M Sell
44,970
-15,304
-25% -$1.2M 0.85% 23
2019
Q4
$5.23M Buy
60,274
+267
+0.4% +$21.9K 0.97% 15
2019
Q3
$4.82M Sell
60,007
-246
-0.4% -$19.7K 0.95% 18
2019
Q2
$4.82M Sell
60,253
-1,685
-3% -$129K 0.97% 19
2019
Q1
$4.92M Sell
61,938
-1,497
-2% -$112K 1.02% 19
2018
Q4
$4.63M Buy
63,435
+729
+1% +$51.5K 1.1% 14
2018
Q3
$4.24M Buy
62,706
+93
+0.1% +$5.92K 0.87% 21
2018
Q2
$3.63M Sell
62,613
-839
-1% -$47.3K 0.79% 28
2018
Q1
$3.3M Buy
63,452
+2,430
+4% +$131K 0.72% 33
2017
Q4
$3.28M Sell
61,022
-750
-1% -$41.6K 0.69% 34
2017
Q3
$3.77M Sell
61,772
-3,332
-5% -$202K 0.82% 26
2017
Q2
$3.98M Buy
65,104
+8,587
+15% +$523K 0.87% 23
2017
Q1
$3.43M Sell
56,517
-3,918
-6% -$238K 0.79% 27
2016
Q4
$3.39M Sell
60,435
-5,680
-9% -$332K 0.81% 28
2016
Q3
$3.94M Buy
66,115
+544
+0.8% +$31.8K 0.96% 23
2016
Q2
$3.6M Buy
65,571
+10
+0% +$532 0.94% 26
2016
Q1
$3.31M Buy
65,561
+1,352
+2% +$66.2K 0.9% 25
2015
Q4
$3.24M Buy
64,209
+25,999
+68% +$1.31M 0.92% 22
2015
Q3
$1.8M Sell
38,210
-203
-0.5% -$10.8K 0.54% 52
2015
Q2
$2.09M Buy
38,413
+236
+0.6% +$13.2K 0.6% 41
2015
Q1
$2.09M Buy
38,177
+713
+2% +$40.4K 0.6% 41
2014
Q4
$2.03M Buy
37,464
+8,433
+29% +$470K 0.64% 34
2014
Q3
$1.64M Sell
29,031
-4,062
-12% -$228K 0.56% 40
2014
Q2
$1.83M Buy
33,093
+2,111
+7% +$115K 0.59% 34
2014
Q1
$1.68M Buy
30,982
+10,983
+55% +$569K 0.63% 32
2013
Q4
$955K Buy
19,999
+713
+4% +$32.6K 0.38% 64
2013
Q3
$876K Sell
19,286
-1,222
-6% -$55.8K 0.4% 66
2013
Q2
$909K Buy
+20,508
New +$916K 0.42% 63

Other funds holding MRK

Private Trust Company's MRK Position: Q2 2026 in Review

Private Trust Company reduced its Merck (MRK) stake by 2.6% in Q2 2026, selling an estimated $151K and leaving 48,857 shares worth $6.28M. The position accounts for 0.5% of the portfolio, ranked #25.

Private Trust Company first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.58M in Q1 2024. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Private Trust Company held 48,857 shares of Merck worth $6.28M as of Q2 2026.
  • Private Trust Company sold 1,287 Merck shares in Q2 2026, an estimated $151K.
  • Merck made up 0.5% of Private Trust Company's portfolio in Q2 2026, its #25 holding.
  • Private Trust Company first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Private Trust Company's Merck position peaked at $6.58M in Q1 2024.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.